Mainstay Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-40	Closed	-$10K	–	342
2018 Q3	$10K	Buy	+40	New	+$10K	0.01%	340